Direct Oral Anticoagulants for Prevention of Venous Thromboembolism after Cancer-Related Surgery: Systematic Review and Network Meta-Analysis

医学 阿哌沙班 拜瑞妥 抗血栓 优势比 荟萃分析 随机对照试验 腹部外科 外科 内科学 低分子肝素 血栓形成 华法林 心房颤动
作者
Gerardo Nicola Pititto,Giorgio Maraziti,Alessandro Squizzato,Cecilia Becattini
出处
期刊:Thrombosis and Haemostasis [Thieme Medical Publishers (Germany)]
卷期号:126 (04): 429-438 被引量:2
标识
DOI:10.1055/a-2628-3967
摘要

The risk of venous thromboembolism (VTE) is high after cancer surgery and is reduced by antithrombotic prophylaxis.We conducted a systematic review and network meta-analysis to evaluate the effectiveness and safety of direct oral anticoagulants (DOACs) for VTE prophylaxis after cancer surgery. The primary study outcome was 30-day VTE after surgery. Pooled odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were estimated.Five randomized controlled trials (RCTs; two gynecological, one abdominal, one neurosurgical, and one thoracic; 1,694 patients) and seven observational studies (three urological, two abdominal, and two gynecological; 2,042 patients) were included. DOACs reduced the incidence of 30-day (OR 0.52, 95% CI 0.27-0.98, I2 22.7%) and 90-day VTE (OR 0.51, 95% CI 0.28-0.92, I2 0%) compared to LMWH. No difference was observed between DOACs and LMWH in 30 and 90-day bleeding outcomes. In random effect analyses, apixaban (OR 0.31, 95% CI 0.11-0.84) and not rivaroxaban reduced the risk of 30 day-VTE compared to LMWH (OR 0.69, 95% CI 0.35-1.34) without increasing the risk of bleeding at 30 or 90 days. No difference in the risk of VTE or bleeding was observed between DOACs and placebo/no treatment, but these analyses were probably underpowered. Subgroup analyses were conducted on LMWH pre-treatment, extended prophylaxis, duration of surgery, and type of surgery.Our study supports apixaban and rivaroxaban as promising alternatives to LMWH in post-operative prophylaxis of VTE after cancer surgery. Further high-quality data are needed in specific surgical settings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
沐沐发布了新的文献求助10
2秒前
风吹麦浪的应助被LJH采纳,获得10
2秒前
3秒前
ccc的应助被Prospect采纳,获得10
3秒前
4秒前
5秒前
爆米花的应助被zhuaini采纳,获得10
5秒前
风吹麦浪的应助被wwj采纳,获得10
5秒前
潇潇发布了新的文献求助10
5秒前
gx_123完成签到,获得积分10
5秒前
Dec完成签到 ,获得积分10
6秒前
呆萌沛蓝完成签到,获得积分10
7秒前
7秒前
慕青的应助被沐沐采纳,获得10
8秒前
123发布了新的文献求助10
8秒前
9秒前
OK发布了新的文献求助10
9秒前
rena521完成签到,获得积分10
9秒前
10秒前
11秒前
小白完成签到 ,获得积分10
12秒前
TwistZz发布了新的文献求助10
13秒前
乐乐的应助被xuexi采纳,获得10
14秒前
番茄鱼憨憨完成签到 ,获得积分10
15秒前
石石石开发布了新的文献求助10
15秒前
15秒前
MM完成签到,获得积分10
16秒前
16秒前
17秒前
慕青的应助被庞伟泽采纳,获得10
17秒前
Lucas的应助被轻松雅青采纳,获得10
18秒前
OK的应助被interguy采纳,获得200
18秒前
18秒前
星眠完成签到,获得积分10
19秒前
molihuakai的应助被千山采纳,获得10
22秒前
22秒前
优雅尔芙发布了新的文献求助10
22秒前
22秒前
悖思囿发布了新的文献求助10
22秒前
Maestro_S的应助被renshiq采纳,获得10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188885
求助须知:如何正确求助?哪些是违规求助? 9576493
关于积分的说明 21847858
捐赠科研通 7786920
什么是DOI,文献DOI怎么找? 3435460
关于科研通互助平台的介绍 2559669
邀请新用户注册赠送积分活动 2482383